A CELEBRATION OF EXCELLENCE, HOE KIAN CHOON AND CUCKOO INTERNATIONAL BAGS THREE AWARDS AT THE ASIA PACIFIC ENTERPRISE AWARDS 2022 MALAYSIA
Hoe Kian Choon, the Founder and CEO of CUCKOO International (MAL) Sdn Bhd named 'Entrepreneur of the Year' in recognition of his passion to positively impact communities through the 'Rent-Subscription Business Model'. CUCKOO International (MAL) Sdn Bhd takes home a win under the Corporate Excellence Category for demonstrating exceptional and consistent business results with seven consecutive year...
TIANGEN to Participate in the 2022 AACC Meeting
CHICAGO, July 22, 2022 /PRNewswire/ -- TIANGEN, a leading brand in the field of nucleic acid purification in China, has announced its participation in the 2022 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo from July 26 to 28 in Chicago where it will be officially launching its brand in the US market. ...
Ascentage Pharma Announces Clinical Trial Application for Olverembatinib (HQP1351) Approved in Canada
SUZHOU, China and ROCKVILLE, MD, July 22, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Phase Ib study of Ascentage Pharma's novel drug candidate, olverembatinib (HQP1351), for the treatment of patients with...
uLab™ clear aligner platform is now available in Australia and New Zealand
MEMPHIS, Tenn., July 22, 2022 /PRNewswire/ -- uLab Systems™, the creator of the uSmile™ clear aligner system and the uDesign® treatment planning software, announces the clearance of the uLab product suite from the Therapeutic Goods Administration (TGA) and Medsafe, the regulatory authorities for therapeutic goods in Australia and New Zealand respectively....
Congratulations! Kexing Biopharm (688136.SH) was awarded by the” Annual Top 20 Chinese Biopharmaceutical Entreprises”
SHENZHEN, China, July 21, 2022 /PRNewswire/ -- On 12 July 2022, Menet held the award ceremony of the "Annual Top 100 China's Pharmaceutical Entreprises in 2021", in which 5 sub-lists of the pharmaceutical industries had been announced. This event showcased the professionalism and influence of the top companies in China's pharmaceutical industry. With the solid R&D and production strength and...
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy
– Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication – – Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) in May 2022 – NEWTON, Mass. and FLORENCE, Italy, July 21, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering...
AI-based Cancer Solution Pioneer Lunit Makes Market Debut
SEOUL, South Korea, July 21, 2022 /PRNewswire/ -- Lunit, a global provider of AI-powered cancer solutions, announced today that it made its stock market debut on the South Korean KOSDAQ under the ticker "A32813". Lunit's initial public offering of 1,215,800 shares of its common stock was priced at KRW 30,000 (US$ 23)...
Waterdrop Launches Industry’s First Customized Critical Illness Insurance Product with Waiver on Health Declarations
BEIJING, July 21, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it has partnered with China United Property Insurance Company Limited ("CIC") and Yong An Insurance ("Yong An") to launch "Waterdrop Blue Ocean", a series of...
Mentice publishes the company’s interim report for the period April – June 2022
GOTHENBURG, Sweden, July 21, 2022 /PRNewswire/ -- The acquisition of Ankyras is finalized and a large order in the quarter The order book increased to 108.9 (67.9) MSEK and compared to 87.1 MSEK at the end of 2021. We acquired all relevant assets relating to Ankyras from Galgo Medical in Spain on the 30th of June. A significant order...
BAXTER HEALTHCARE ANNOUNCES STEVEN FLYNN TO LEAD ASIA PACIFIC REGION
SINGAPORE, July 21, 2022 /PRNewswire/ -- Baxter International, a global medtech leader, has announced the appointment of Steven (Steve) Flynn to Senior Vice President and President Baxter Asia Pacific. Mr Steven Flynn - Senior Vice President and President Asia Pacific, Baxter Mr Flynn, who has served as General Manager of Baxter Australia and New Zealand since 2015,...
